can tirzepatide cause kidney stones Renal effects of GLP-1 receptor agonists and in individuals with type 2 diabetes: seeds of a promising future | Endocrine Kidney Stones and Wegovy: What

Another study found that there was an even higher risk of developing hypothyroidism in patients with type 1 diabetes who also had TPO antibodies they were 18 times more likely to develop hypothyroidism compared to patients with type 1 diabetes without TPO antibodies

Zhang, Hua

Research indicates that higher glutathione levels are associated with better cellular function and longevity

Paraventricular hypothalamic nucleus CRH neuron activation by central GLP1 may also have a modulating/attenuating effect on GLP1's inhibitory effect on eating by stimulating the hypothalamus and pituitary adrenal axis (Lee et al., 2016)

At first, yes